(DMAC) Diamedica Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Diamedica Therapeutics | (DMAC) share price targets
Complete technical analysis of Diamedica Therapeutics (DMAC) by charts plus indicators, forecast predictions and share price targets for Diamedica Therapeutics (DMAC)
Diamedica Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-06 View latest technical analysis
10 day averaged volume of Diamedica Therapeutics is 38220
| Date | Daily Closing Price | Open | High | Low | Volume |
| 06 Wed Nov 2024 | 4.33 | 4.37 | 4.41 | 4.27 | 1.164 times |
| 05 Tue Nov 2024 | 4.37 | 4.44 | 4.44 | 4.35 | 0.701 times |
| 04 Mon Nov 2024 | 4.43 | 4.28 | 4.44 | 4.21 | 0.62 times |
| 01 Fri Nov 2024 | 4.25 | 4.39 | 4.40 | 4.05 | 1.813 times |
| 31 Thu Oct 2024 | 4.37 | 4.34 | 4.48 | 4.18 | 1.211 times |
| 30 Wed Oct 2024 | 4.36 | 4.33 | 4.40 | 4.26 | 0.628 times |
| 29 Tue Oct 2024 | 4.32 | 4.30 | 4.40 | 4.30 | 0.651 times |
| 28 Mon Oct 2024 | 4.30 | 4.39 | 4.44 | 4.27 | 0.986 times |
| 25 Fri Oct 2024 | 4.39 | 4.34 | 4.43 | 4.26 | 1.047 times |
| 24 Thu Oct 2024 | 4.34 | 4.31 | 4.36 | 4.16 | 1.007 times |
My analysis of stock is bearish for shortterm, and stock might move down till 4.3 or till 4.2. Use a stoploss of 4.35 and if the stock hits stoploss, then it can shoot up till 4.41
Share price targets for Diamedica Therapeutics (DMAC)
| Target Type | Value |
| Downside Target | 2.65 |
| Downside Target | 3.25 |
| Downside Target | 3.76 |
| Downside Target | 4.05 |
| Upside Target | 4.44 |
| Upside Target | 4.48 |
| Upside Target | 4.50 |
| Upside Target | 4.77 |
| Upside Target | 4.95 |
Intraday share price targets for Diamedica Therapeutics (DMAC)
| Target Type | Value |
| Downside Intraday Target | 4.21 |
| Downside Intraday Target | 4.1 |
| Upside Intraday Target | 4.44 |
| Upside Intraday Target | 4.56 |
| Downside Intraday Target | 4.33 |
Weekly technical analysis of Diamedica Therapeutics (DMAC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 06 Wed Nov 2024 | 4.33 | 4.28 | 4.44 | 4.21 | 0.47 times |
| 01 Fri Nov 2024 | 4.25 | 4.39 | 4.48 | 4.05 | 1.265 times |
| 25 Fri Oct 2024 | 4.39 | 4.29 | 4.48 | 4.16 | 0.913 times |
| 18 Fri Oct 2024 | 4.34 | 4.30 | 4.50 | 4.21 | 0.409 times |
| 11 Fri Oct 2024 | 4.25 | 4.46 | 4.77 | 4.18 | 2.266 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Diamedica Therapeutics (DMAC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 06 Wed Nov 2024 | 4.33 | 4.39 | 4.44 | 4.05 | 0.155 times |
| 31 Thu Oct 2024 | 4.37 | 4.17 | 4.77 | 4.11 | 0.797 times |
| 30 Mon Sep 2024 | 4.19 | 4.01 | 4.95 | 3.76 | 1.604 times |
| 30 Fri Aug 2024 | 3.93 | 3.46 | 4.07 | 3.25 | 0.55 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Diamedica Therapeutics (DMAC)
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Diamedica Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Diamedica Therapeutics in short term but the sell signal is initial and weak.
Diamedica Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Diamedica Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Diamedica Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.33 and Diamedica Therapeutics (DMAC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Diamedica Therapeutics (DMAC) stock. Volume based technical analysis of Diamedica Therapeutics (DMAC) stock is negative.
Diamedica Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Diamedica Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Diamedica Therapeutics in short term but the sell signal is initial and weak.
Diamedica Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Diamedica Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Diamedica Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.33 and Diamedica Therapeutics (DMAC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Diamedica Therapeutics (DMAC) stock. Volume based technical analysis of Diamedica Therapeutics (DMAC) stock is negative.
Diamedica Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.